CME Group Inc. stock steadies after modest pullback on Q2 2026 earnings strength
Published on 09/17/2026 at 17:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
CME Group Inc. stock (ISIN US12572Q1058) closed at USD 200.54 on Nasdaq on September 16, 2026, representing a 0.8 percent decline from the prior day’s USD 202.16 close according to Nasdaq quote data as cited by Ad-hoc news on September 17, 2026.
Q2 2026 results underpin the valuation
According to Stock Titan summarizing CME Group Inc.’s Form 10-Q for the quarter ended June 30, 2026, the company generated total Q2 2026 revenues of USD 1,706.2 million, slightly above the Q2 2025 level.
For the same quarter, CME Group Inc. reported net income of USD 1,041.8 million and diluted earnings per share (EPS) of USD 2.88, compared with net income of USD 1,025.1 million and diluted EPS of USD 2.81 in Q2 2025, indicating EPS growth of around 2.5 percent year over year as highlighted by Stock Titan.
Over the first six months of 2026, CME Group Inc. achieved revenues of USD 3,586.3 million and net income of USD 2,196.1 million, with diluted EPS of USD 6.06 for the six-month period ended June 30, 2026, as reported by Stock Titan.
Longer-term performance and valuation context
CME Group Inc. stock has risen about 5.8 percent over roughly the past year, a move that compares favorably with a 9.4 percent decline for the broader securities industry according to an analysis from The Globe and Mail dated September 16, 2026.
As of that analysis, CME Group Inc. shares were trading at a forward price-to-earnings multiple of 21.73 times, compared with an industry average of 20.65 times, indicating that the stock commands a premium valuation relative to peers according to The Globe and Mail.
The same source notes that the consensus estimate compiled by Zacks for CME Group Inc.’s 2026 EPS implies a 9.5 percent year-over-year increase, while the consensus for 2026 revenues is pegged at USD 7.03 billion, indicating expected top-line growth of 7.8 percent compared with 2025, with a Zacks average price target of USD 284.40 per share, suggesting a potential upside of 1.4 percent from the referenced last closing price, and the stock carrying a Zacks Rank 3 (Hold) as reported by The Globe and Mail.
Stock trading range and recent session dynamics
In trading on September 16, 2026, CME Group Inc. shares moved between an intraday low of USD 198.76 and an intraday high of USD 201.71 on Nasdaq, before closing at USD 200.54, so the closing price remained within a relatively narrow intraday range according to the session summary cited by Ad-hoc news.
The same report notes that CME Group Inc. stock’s 0.8 percent loss on September 16, 2026 came against a roughly 1.2 percent decline in the Dow Jones Industrial Average, indicating that while the stock pulled back, it still held up somewhat better than the broader blue-chip benchmark over that session, as described by Ad-hoc news.
Taking the year-over-year share price increase of 5.8 percent together with the modest single-session decline of 0.8 percent and the premium forward valuation multiples suggests that investors are still willing to pay up for CME Group Inc. stock based on the company’s earnings power and growth prospects, even as day-to-day volatility can produce short-term pullbacks.
Closing price perspective for CME Group Inc. stock
Per Nasdaq trading data referenced by Ad-hoc news, CME Group Inc. stock’s closing level of USD 200.54 on Nasdaq on September 16, 2026, following a prior close of USD 202.16, provides the latest completed-session benchmark for investors assessing the derivatives exchange operator’s shares ahead of the next trading day in September 2026.
CME Group Inc. stock key data
- Company: CME Group Inc.
- ISIN: US12572Q1058
- Ticker: CME
- Trading venue: Nasdaq
- Price (as of September 16, 2026): 200.54 USD
- Sector / Industry: Financials / Exchanges and data
- Index membership: S&P 500
